| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.066 | 0.2 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.063 | 0.3 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.3 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |